Recent advances in telecommunication technologies have boosted the possibility to deliver
rehabilitation via the internet (ie telerehabilitation). Several studies have shown that …

Measurement of exercise capacity is an integral element in assessment of patients with
cardiopulmonary disease. The 6‐min walk test (6MWT) provides information regarding …

Despite the development of pharmacological therapies that are effective in slowing the
progression of idiopathic pulmonary fibrosis (IPF), it remains a debilitating and lethal …

Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1%
of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary …

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, interstitial lung
disease, with few therapeutic options. IPF is characterized by pulmonary restriction …

Background Few data are available on the long-term effect of pulmonary rehabilitation (PR)
and on long PR programs in interstitial lung diseases (ILD). We aimed to evaluate the effects …

Background Pulmonary rehabilitation improves outcomes in patients with interstitial lung
disease (ILD), however it is unclear whether these effects are long lasting and which …

Pulmonary rehabilitation is recommended for patients with chronic lung diseases including
idiopathic pulmonary fibrosis according to international guidelines. However, data for …

The prognosis in idiopathic pulmonary fibrosis (IPF) is poor. No therapy has been shown to
prolong survival. The objective of this study was to examine the prognostic significance of …

Idiopathic pulmonary fibrosis (IPF) occurs predominantly in middle-aged and older adults
and accounts for 20% to 30% of interstitial lung diseases. It is usually progressive, resulting …